Global Gastroparesis Drugs Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	198 Pages	TechNavio	December, 2024	INF19463266

Best Price Guarantee
Price	from $2,500
Length	198 Pages
Publisher	TechNavio
Published Date	December, 2024
SKU	INF19463266

Gastroparesis Drugs Market 2025-2029

The gastroparesis drugs market is forecasted to grow by USD 1338.7 mn during 2024-2029, accelerating at a CAGR of 3.5% during the forecast period. The report on the gastroparesis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, increasing prevalence of gastroparesis, and increasing awareness about gastroparesis.

Technavio's gastroparesis drugs market is segmented as below:

By Drug Class

Prokinetic agents
Antiemetics
Botulinum toxin injection

By Disease Type

Idiopathic gastroparesis
Diabetic gastroparesis
Post-surgical gastroparesis

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing growth opportunities in emerging markets as one of the prime reasons driving the gastroparesis drugs market growth during the next few years. Also, increasing number of clinical research and rising funding in healthcare industry will lead to sizable demand in the market.

The report on the gastroparesis drugs market covers the following areas:

Gastroparesis Drugs Market sizing
Gastroparesis Drugs Market forecast
Gastroparesis Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastroparesis drugs market vendors that include Abbott Laboratories, AbbVie Inc., Aclipse Therapeutics, ANI Pharmaceuticals Inc., Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Eisai Co. Ltd., Evoke Pharma Inc., GlaxoSmithKline Plc, Ipca Laboratories, Johnson and Johnson Inc., Medtronic Plc, Neurogastrx Inc., Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Processa Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., Theravance Biopharma Inc., and Vanda Pharmaceuticals Inc.. Also, the gastroparesis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Drug Class; Executive Summary - Chart on Market Segmentation by Disease Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Gastroparesis Drugs Market 2019 - 2023; Historic Market Size - Data Table on Global Gastroparesis Drugs Market 2019 - 2023 ($ million); 5.2 Drug Class segment analysis 2019 - 2023; Historic Market Size - Drug Class Segment 2019 - 2023 ($ million); 5.3 Disease Type segment analysis 2019 - 2023; Historic Market Size - Disease Type Segment 2019 - 2023 ($ million); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI in Global Gastroparesis Drugs Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Drug Class: 8.1 Market segments; Chart on Drug Class - Market share 2024-2029 (%); Data Table on Drug Class - Market share 2024-2029 (%); 8.2 Comparison by Drug Class; Chart on Comparison by Drug Class; Data Table on Comparison by Drug Class; 8.3 Prokinetic agents - Market size and forecast 2024-2029; Chart on Prokinetic agents - Market size and forecast 2024-2029 ($ million); Data Table on Prokinetic agents - Market size and forecast 2024-2029 ($ million); Chart on Prokinetic agents - Year-over-year growth 2024-2029 (%); Data Table on Prokinetic agents - Year-over-year growth 2024-2029 (%); 8.4 Antiemetics - Market size and forecast 2024-2029; Chart on Antiemetics - Market size and forecast 2024-2029 ($ million); Data Table on Antiemetics - Market size and forecast 2024-2029 ($ million); Chart on Antiemetics - Year-over-year growth 2024-2029 (%); Data Table on Antiemetics - Year-over-year growth 2024-2029 (%); 8.5 Botulinum toxin injection - Market size and forecast 2024-2029; Chart on Botulinum toxin injection - Market size and forecast 2024-2029 ($ million); Data Table on Botulinum toxin injection - Market size and forecast 2024-2029 ($ million); Chart on Botulinum toxin injection - Year-over-year growth 2024-2029 (%); Data Table on Botulinum toxin injection - Year-over-year growth 2024-2029 (%); 8.6 Market opportunity by Drug Class; Market opportunity by Drug Class ($ million); Data Table on Market opportunity by Drug Class ($ million)
9 Market Segmentation by Disease Type: 9.1 Market segments; Chart on Disease Type - Market share 2024-2029 (%); Data Table on Disease Type - Market share 2024-2029 (%); 9.2 Comparison by Disease Type; Chart on Comparison by Disease Type; Data Table on Comparison by Disease Type; 9.3 Idiopathic gastroparesis - Market size and forecast 2024-2029; Chart on Idiopathic gastroparesis - Market size and forecast 2024-2029 ($ million); Data Table on Idiopathic gastroparesis - Market size and forecast 2024-2029 ($ million); Chart on Idiopathic gastroparesis - Year-over-year growth 2024-2029 (%); Data Table on Idiopathic gastroparesis - Year-over-year growth 2024-2029 (%); 9.4 Diabetic gastroparesis - Market size and forecast 2024-2029; Chart on Diabetic gastroparesis - Market size and forecast 2024-2029 ($ million); Data Table on Diabetic gastroparesis - Market size and forecast 2024-2029 ($ million); Chart on Diabetic gastroparesis - Year-over-year growth 2024-2029 (%); Data Table on Diabetic gastroparesis - Year-over-year growth 2024-2029 (%); 9.5 Post-surgical gastroparesis - Market size and forecast 2024-2029; Chart on Post-surgical gastroparesis - Market size and forecast 2024-2029 ($ million); Data Table on Post-surgical gastroparesis - Market size and forecast 2024-2029 ($ million); Chart on Post-surgical gastroparesis - Year-over-year growth 2024-2029 (%); Data Table on Post-surgical gastroparesis - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Disease Type; Market opportunity by Disease Type ($ million); Data Table on Market opportunity by Disease Type ($ million)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.9 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.10 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.11 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 11.12 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.13 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.14 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ million); Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 11.15 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.16 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; SWOT; 14.5 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 14.6 ANI Pharmaceuticals Inc.; ANI Pharmaceuticals Inc. - Overview; ANI Pharmaceuticals Inc. - Product / Service; ANI Pharmaceuticals Inc. - Key offerings; SWOT; 14.7 Bausch Health Companies Inc.; Bausch Health Companies Inc. - Overview; Bausch Health Companies Inc. - Business segments; Bausch Health Companies Inc. - Key news; Bausch Health Companies Inc. - Key offerings; Bausch Health Companies Inc. - Segment focus; SWOT; 14.8 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; SWOT; 14.9 Eisai Co. Ltd.; Eisai Co. Ltd. - Overview; Eisai Co. Ltd. - Business segments; Eisai Co. Ltd. - Key offerings; Eisai Co. Ltd. - Segment focus; SWOT; 14.10 Evoke Pharma Inc.; Evoke Pharma Inc. - Overview; Evoke Pharma Inc. - Product / Service; Evoke Pharma Inc. - Key offerings; SWOT; 14.11 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 14.12 Ipca Laboratories; Ipca Laboratories - Overview; Ipca Laboratories - Product / Service; Ipca Laboratories - Key offerings; SWOT; 14.13 Medtronic Plc; Medtronic Plc - Overview; Medtronic Plc - Business segments; Medtronic Plc - Key news; Medtronic Plc - Key offerings; Medtronic Plc - Segment focus; SWOT; 14.14 Otsuka Pharmaceutical Co. Ltd.; Otsuka Pharmaceutical Co. Ltd. - Overview; Otsuka Pharmaceutical Co. Ltd. - Product / Service; Otsuka Pharmaceutical Co. Ltd. - Key offerings; SWOT; 14.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.16 Processa Pharmaceuticals Inc.; Processa Pharmaceuticals Inc. - Overview; Processa Pharmaceuticals Inc. - Product / Service; Processa Pharmaceuticals Inc. - Key offerings; SWOT; 14.17 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; SWOT; 14.18 Vanda Pharmaceuticals Inc.; Vanda Pharmaceuticals Inc. - Overview; Vanda Pharmaceuticals Inc. - Product / Service; Vanda Pharmaceuticals Inc. - Key offerings; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class; Exhibits6: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Gastroparesis Drugs Market 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Drug Class - Market share 2024-2029 (%); Exhibits37: Data Table on Drug Class - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Drug Class; Exhibits39: Data Table on Comparison by Drug Class; Exhibits40: Chart on Prokinetic agents - Market size and forecast 2024-2029 ($ million); Exhibits41: Data Table on Prokinetic agents - Market size and forecast 2024-2029 ($ million); Exhibits42: Chart on Prokinetic agents - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on Prokinetic agents - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on Antiemetics - Market size and forecast 2024-2029 ($ million); Exhibits45: Data Table on Antiemetics - Market size and forecast 2024-2029 ($ million); Exhibits46: Chart on Antiemetics - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Antiemetics - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Botulinum toxin injection - Market size and forecast 2024-2029 ($ million); Exhibits49: Data Table on Botulinum toxin injection - Market size and forecast 2024-2029 ($ million); Exhibits50: Chart on Botulinum toxin injection - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Botulinum toxin injection - Year-over-year growth 2024-2029 (%); Exhibits52: Market opportunity by Drug Class ($ million); Exhibits53: Data Table on Market opportunity by Drug Class ($ million); Exhibits54: Chart on Disease Type - Market share 2024-2029 (%); Exhibits55: Data Table on Disease Type - Market share 2024-2029 (%); Exhibits56: Chart on Comparison by Disease Type; Exhibits57: Data Table on Comparison by Disease Type; Exhibits58: Chart on Idiopathic gastroparesis - Market size and forecast 2024-2029 ($ million); Exhibits59: Data Table on Idiopathic gastroparesis - Market size and forecast 2024-2029 ($ million); Exhibits60: Chart on Idiopathic gastroparesis - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Idiopathic gastroparesis - Year-over-year growth 2024-2029 (%); Exhibits62: Chart on Diabetic gastroparesis - Market size and forecast 2024-2029 ($ million); Exhibits63: Data Table on Diabetic gastroparesis - Market size and forecast 2024-2029 ($ million); Exhibits64: Chart on Diabetic gastroparesis - Year-over-year growth 2024-2029 (%); Exhibits65: Data Table on Diabetic gastroparesis - Year-over-year growth 2024-2029 (%); Exhibits66: Chart on Post-surgical gastroparesis - Market size and forecast 2024-2029 ($ million); Exhibits67: Data Table on Post-surgical gastroparesis - Market size and forecast 2024-2029 ($ million); Exhibits68: Chart on Post-surgical gastroparesis - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Post-surgical gastroparesis - Year-over-year growth 2024-2029 (%); Exhibits70: Market opportunity by Disease Type ($ million); Exhibits71: Data Table on Market opportunity by Disease Type ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on South Korea - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on South Korea - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on Italy - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on Italy - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits133: Market opportunity By Geographical Landscape ($ million); Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits135: Impact of drivers and challenges in 2024 and 2029; Exhibits136: Overview on criticality of inputs and factors of differentiation; Exhibits137: Overview on factors of disruption; Exhibits138: Impact of key risks on business; Exhibits139: Companies covered; Exhibits140: Company ranking index; Exhibits141: Matrix on companies position and classification; Exhibits142: Abbott Laboratories - Overview; Exhibits143: Abbott Laboratories - Business segments; Exhibits144: Abbott Laboratories - Key news; Exhibits145: Abbott Laboratories - Key offerings; Exhibits146: Abbott Laboratories - Segment focus; Exhibits147: SWOT; Exhibits148: AbbVie Inc. - Overview; Exhibits149: AbbVie Inc. - Product / Service; Exhibits150: AbbVie Inc. - Key news; Exhibits151: AbbVie Inc. - Key offerings; Exhibits152: SWOT; Exhibits153: ANI Pharmaceuticals Inc. - Overview; Exhibits154: ANI Pharmaceuticals Inc. - Product / Service; Exhibits155: ANI Pharmaceuticals Inc. - Key offerings; Exhibits156: SWOT; Exhibits157: Bausch Health Companies Inc. - Overview; Exhibits158: Bausch Health Companies Inc. - Business segments; Exhibits159: Bausch Health Companies Inc. - Key news; Exhibits160: Bausch Health Companies Inc. - Key offerings; Exhibits161: Bausch Health Companies Inc. - Segment focus; Exhibits162: SWOT; Exhibits163: Cadila Pharmaceuticals Ltd. - Overview; Exhibits164: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits165: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits166: SWOT; Exhibits167: Eisai Co. Ltd. - Overview; Exhibits168: Eisai Co. Ltd. - Business segments; Exhibits169: Eisai Co. Ltd. - Key offerings; Exhibits170: Eisai Co. Ltd. - Segment focus; Exhibits171: SWOT; Exhibits172: Evoke Pharma Inc. - Overview; Exhibits173: Evoke Pharma Inc. - Product / Service; Exhibits174: Evoke Pharma Inc. - Key offerings; Exhibits175: SWOT; Exhibits176: GlaxoSmithKline Plc - Overview; Exhibits177: GlaxoSmithKline Plc - Business segments; Exhibits178: GlaxoSmithKline Plc - Key news; Exhibits179: GlaxoSmithKline Plc - Key offerings; Exhibits180: GlaxoSmithKline Plc - Segment focus; Exhibits181: SWOT; Exhibits182: Ipca Laboratories - Overview; Exhibits183: Ipca Laboratories - Product / Service; Exhibits184: Ipca Laboratories - Key offerings; Exhibits185: SWOT; Exhibits186: Medtronic Plc - Overview; Exhibits187: Medtronic Plc - Business segments; Exhibits188: Medtronic Plc - Key news; Exhibits189: Medtronic Plc - Key offerings; Exhibits190: Medtronic Plc - Segment focus; Exhibits191: SWOT; Exhibits192: Otsuka Pharmaceutical Co. Ltd. - Overview; Exhibits193: Otsuka Pharmaceutical Co. Ltd. - Product / Service; Exhibits194: Otsuka Pharmaceutical Co. Ltd. - Key offerings; Exhibits195: SWOT; Exhibits196: Pfizer Inc. - Overview; Exhibits197: Pfizer Inc. - Product / Service; Exhibits198: Pfizer Inc. - Key news; Exhibits199: Pfizer Inc. - Key offerings; Exhibits200: SWOT; Exhibits201: Processa Pharmaceuticals Inc. - Overview; Exhibits202: Processa Pharmaceuticals Inc. - Product / Service; Exhibits203: Processa Pharmaceuticals Inc. - Key offerings; Exhibits204: SWOT; Exhibits205: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits206: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits207: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits208: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits209: SWOT; Exhibits210: Vanda Pharmaceuticals Inc. - Overview; Exhibits211: Vanda Pharmaceuticals Inc. - Product / Service; Exhibits212: Vanda Pharmaceuticals Inc. - Key offerings; Exhibits213: SWOT; Exhibits214: Inclusions checklist; Exhibits215: Exclusions checklist